First AD

Second AD

The Impact of Emerging Resistance Patterns on Treatment Sequencing in R/R CLL

Video content above is prompted by the following:

How do developing resistance patterns impact treatment sequencing?

Insights

Insights is an expert interview video series of leading oncologists that provides in-depth reports and feature segments profiling leaders in a range of oncology disciplines, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecologic cancers, and hematologic malignancies. Most episodes feature 2 clinicians discussing the latest oncology advances in clinical practice. 

Optimizing R/R CLL Treatment: Therapy Sequencing and Supportive Care Strategies

Panelists discuss how emerging resistance patterns in chronic lymphocytic leukemia influence their approach to treatment sequencing, considering the mechanisms of resistance to different drug classes and how this knowledge informs the selection and order of therapies to maximize long-term disease control and patient outcomes.

The Current Treatment Landscape for R/R CLL

Impact of Prior BTKi vs BCL2i Therapy on Treatment Decision-Making in CLL 